DALEMANS
ActiveSummary
DALEMANS has been active since 1979 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €500,348 and a net result of -€22,317. Equity has been stable since 2018 (±2.4% per year). Its solvency ranks better than 56% of 12,777 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.9% (low).
Overview
Overview
Official details
Source: KBO- Status
- Active since 21-12-1979 Normal situation
- Activity
- Retail sale of pharmaceutical products NACE 47730
- Joint committee
- 313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2021
- Establishment unit
- 2.016.972.567 9255 Buggenhout, since 01-01-1980
- Financial year end
- 31 December
- Peppol
- Reachable since 21-10-2026
Board and ownership
Board
- DALIDirector · permanent representative DALEMANS Carla
Shareholders
- DALI100%2025 annual accounts of DALI
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.9%
Annual accounts 2025
- Gross margin
- €63,647
- ▲ 0.5%
- Turnover
- ≈ €310,000
- estimated
- Loss
- €22,317
- Equity
- €500,348
- ▼ 4.3%
- Total assets
- €1.2m
- ▲ 22.2%
- Employees on 31-12-2025
- 1
- 2025 accounts filed 31 days after the deadline
Score breakdownraises risk1 change of registered office in 24 monthsLast filed accounts filed 31 days late; 3 of the last 3 accounts lateLiquidity: current ratio 1.25, cash €60,253, halvedlowers riskSize: 1 FTE, total assets €1.2mShow the evidence
Checked score
Score 2025
67
/ 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially stronger than 40% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2024
Average
Solvency
67-11
equity 41.8% of total assets
Liquidity
48-38
short-term debt 23.3% · cash 5.0%
Profitability
29-23
return on assets -1.9%
Bankruptcy probability within 12 months
0.9%
Low
0%0.5%1.5%4%10%≥ 25%
About 9 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.1%
01-2025: 0.1%● unchanged vs 12-2024
02-2025: 0.1%● unchanged vs 01-2025
03-2025: 0.1%● unchanged vs 02-2025
04-2025: 0.1%● unchanged vs 03-2025
05-2025: 0.1%● unchanged vs 04-2025
06-2025: 0.1%● unchanged vs 05-2025
07-2025: 0.1%● unchanged vs 06-2025
08-2025: 0.2%▲ +0.1 percentage points vs 07-2025
09-2025: 0.3%▲ +0.1 percentage points vs 08-2025
10-2025: 0.4%▲ +0.1 percentage points vs 09-2025
11-2025: 0.1%▼ -0.3 percentage points vs 10-2025
12-2025: 0.1%● unchanged vs 11-2025
01-2026: 0.1%● unchanged vs 12-2025
02-2026: 0.1%● unchanged vs 01-2026
03-2026: 0.1%● unchanged vs 02-2026
04-2026: 0.1%● unchanged vs 03-2026
05-2026: 0.1%● unchanged vs 04-2026
06-2026: 0.1%● unchanged vs 05-2026lowest value
07-2026: 0.1%● unchanged vs 06-2026
08-2026: 0.5%▲ +0.4 percentage points vs 07-2026
09-2026: 0.9%▲ +0.4 percentage points vs 08-2026highest value
10-2026: 0.9%● unchanged vs 09-2026highest value
11-2026: 0.9%● unchanged vs 10-2026highest value
Credit of up to €30,000 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.25 (3.04 in 2024), below the usual 1.5. Short-term debt is 23.3% and cash 5% of total assets. 58.2% of the assets are financed with debt and provisions.
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 57% of them on solvency, 48% on liquidity, 24% on profitability and 32% on growth.
The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises risk
raises risk · 2025 accounts filed 31 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filingsDeviation from the deadline
2025
31 days late
2024
74 days late
2023
57 days late
2022
144 days late
2021
26 days late
2020
30 days late
2019
28 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 56 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 27 September (4 of the last 5 accounts filed within 32 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
04-11-2026 today31-12-2026 year end31-07-2027 deadline
Financials
Financials · financial year 2025, abbreviated format
2025 annual accounts filed 31 days after the deadline Filed on 31 August 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00479212.
Annual accounts 2025 filed on 31-08-2026 at the NBB all 46 filings
Turnover
≈ €310,000
Estimated: probably between €150,000 and €450,000
Total assets
€1.2m▲ 22.2%
2024 · €980,171
Net result
-€22,317
2024 · €22,738
Working capital
€70,339▼ 84.9%
2024 · €466,557
Multi-year overview
2018 to 2025, 8 financial yearsOperating result
€3,648
▼ 92.3%
2025
20182025
Net result
-€22,317
2025
lowest quarter of the sector
20182025
Equity
€500,348
▼ 4.3%
2025
middle half of the sector
20182025
Total assets
€1.2m
▲ 22.2%
2025
middle half of the sector
20182025
Debt
€697,551
▲ 52.5%
2025
20182025
Working capital
€70,339
▼ 84.9%
2025
middle half of the sector
20182025
Solvency
41.8%
▼ 11.6pp
2025
middle half of the sector
20182025
Current ratio
1.25
▼ 1.79
2025
middle half of the sector
20182025
Return on assets (ROA)
-1.9%
▼ 4.2pp
2025
lowest quarter of the sector
20182025
Staff (FTE)
1
2025
lowest quarter of the sector
20182025
Every figure per financial year
Every figure with its change against the financial year before
favourable
unfavourable
Line20182019202020212022202320242025
Operating result-€0.02m--€0.01m▲ 38.6%€0.008m€0.01m▲ 18.0%€405▼ 95.8%€0.02m▲ 58×€0.05m▲ 100%€0.004m▼ 92.3%
Net result-€0.02m--€0.02m▲ 19.9%-€0.001mwithin the sector's middle half▲ 96.2%€0.1mabove the sector's middle half-€0.001mwithin the sector's middle half€0.01mwithin the sector's middle half€0.02mwithin the sector's middle half▲ 127%-€0.02mbelow the sector's middle half
Equity€0.4m-€0.4m▼ 4.1%€0.4mabove the sector's middle half▼ 0.2%€0.5mabove the sector's middle half▲ 24.2%€0.5mabove the sector's middle half▼ 0.2%€0.5mwithin the sector's middle half▲ 2.0%€0.5mwithin the sector's middle half=€0.5mwithin the sector's middle half▼ 4.3%
Total assets€0.6m-€0.5m▼ 4.1%€0.5mabove the sector's middle half▲ 2.8%€0.7mabove the sector's middle half▲ 24.0%€0.6mabove the sector's middle half▼ 6.3%€1.0mwithin the sector's middle half▲ 64.4%€1.0mwithin the sector's middle half▼ 5.6%€1.2mwithin the sector's middle half▲ 22.2%
Debt€0.1m-€0.1m▼ 4.0%€0.1m▲ 13.4%€0.2m▲ 23.4%€0.1m▼ 25.9%€0.5m▲ 333%€0.5m▼ 11.3%€0.7m▲ 52.5%
Working capital€0.4m-€0.4m▼ 2.2%€0.4mabove the sector's middle half▲ 0.6%€0.5mabove the sector's middle half▲ 25.0%€0.5mabove the sector's middle half▲ 1.2%€0.5mwithin the sector's middle half▼ 11.2%€0.5mwithin the sector's middle half▲ 1.7%€0.07mwithin the sector's middle half▼ 84.9%
Solvency78.3%-78.3%=76.0%above the sector's middle half▼ 2.2pp76.1%above the sector's middle half▲ 0.1pp81.1%above the sector's middle half▲ 5.0pp50.3%within the sector's middle half▼ 30.8pp53.3%within the sector's middle half▲ 3.0pp41.8%within the sector's middle half▼ 11.6pp
Current ratio4.54-4.58▲ 0.044.17above the sector's middle half▼ 0.414.19above the sector's middle half▲ 0.025.57above the sector's middle half▲ 1.382.63within the sector's middle half▼ 2.943.04above the sector's middle half▲ 0.411.25within the sector's middle half▼ 1.79
Return on assets (ROA)-4.0%--3.4%▲ 0.7pp-0.1%within the sector's middle half▲ 3.2pp14.8%above the sector's middle half▲ 14.9pp-0.2%within the sector's middle half▼ 15.0pp1.0%within the sector's middle half▲ 1.1pp2.3%within the sector's middle half▲ 1.4pp-1.9%below the sector's middle half▼ 4.2pp
Staff (FTE)1-1=1within the sector's middle half=1=1below the sector's middle half
above
within
below
The sector band is the middle half of the companies in Retail trade (NACE 47). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30.
The operating result for 2025 is 92% lower than in 2024.
Turnover and EBIT margin are not published. The abbreviated or micro format does not require them. The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.2m
Fixed assets
€848,233 ▲ 198%
Current assets
€349,666 ▼ 49.7%
Equity and liabilities €1.2m
Equity
€500,348 ▼ 4.3%
Debt
€697,551 ▲ 52.5%
Debt's share of the balance-sheet total rises from 46.7% to 58.2%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€39,786▼
2024 · €61,361
Cash flow
€13,821▼
2024 · €36,848
Quick ratio
0.89▼
2024 · 2.66
Debt to equity
1.39▲
2024 · 0.88
ROE
-4.5%▼
2024 · 4.4%
Interest coverage
1.52▼
2024 · 3.60
Debt ≤ 1 year
€279,327▲
2024 · €228,745
Debt > 1 year
€411,908▲
2024 · €224,308
Staff costs
€15,184
Green means a favourable move, even when the figure itself falls, as with debt or debt to equity.
Staff
| Item | 31-12-2021 | 31-12-2025 |
|---|---|---|
| Employees at the balance-sheet date | 1 | 1 |
| full-time | 1 | 1 |
| part-time | 0 | - |
| in full-time equivalents | 1 | 1 |
| Average over the year, in full-time equivalents | 1 | 1 |
| On a permanent contract | 1 | 1 |
| Joined | 1 | 1 |
| Left | 1 | 0 |
Source: social balance sheet in the 2021 to 2025 annual accounts
Investments
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Tangible fixed assets | - | - | €317,623 | - | €599,503 |
| Financial fixed assets | €160 | - | - | - | - |
| Depreciation and write-downs of the year | €2,911 | €995 | €20,818 | €14,111 | €36,138 |
Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)
Annual accounts
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | - | - | - | €51,871 | €70,558 | - | - | €15,184 | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €9,730 | €9,774 | €3,179 | €2,911 | €995 | €20,818 | €14,111 | €36,138 | ▲ 156% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4 | - | - | - | - | €3,493 | €587 | - | - | - |
| Other operating charges640/8 | - | - | - | €1,252 | €2,337 | €2,011 | €1,968 | €8,677 | ▲ 341% |
| Gross operating margin9900 | €52,541 | €59,242 | €75,068 | €65,703 | €77,788 | €47,006 | €63,329 | €63,647 | ▲ 0.5% |
| Operating profit (loss)9901 | -€18,773 | -€11,520 | €8,194 | €9,669 | €405 | €23,590 | €47,251 | €3,648 | ▼ 92.3% |
| Financial income75/76B | - | - | - | €124,394 | €2,759 | €338 | €332 | €295 | ▼ 11.0% |
| Recurring financial income75 | €5,780 | €11,189 | €0 | €124,394 | €2,759 | €338 | €332 | €295 | ▼ 11.0% |
| Financial charges65/66B | - | - | - | €15,795 | €4,184 | €12,815 | €17,066 | €26,260 | ▲ 53.9% |
| Recurring financial charges65 | €9,017 | €17,283 | €8,736 | €15,795 | €4,184 | €12,815 | €17,066 | €26,260 | ▲ 53.9% |
| Profit (loss) for the period before taxes9903 | -€22,009 | -€17,614 | -€542 | €118,268 | -€1,020 | €11,114 | €30,517 | -€22,317 | - |
| Income taxes67/77 | €155 | €140 | €128 | €18,278 | €69 | €1,083 | €7,779 | - | - |
| Profit (loss) for the period9904 | -€22,165 | -€17,755 | -€670 | €99,990 | -€1,090 | €10,031 | €22,738 | -€22,317 | - |
| Transfer from tax-exempt reserves789 | - | - | - | - | - | - | - | €6,000 | - |
| Profit (loss) for the period to be appropriated9905 | -€22,165 | -€17,755 | -€670 | €99,990 | -€1,090 | €10,031 | €22,738 | -€16,317 | - |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Total assets20/58 | €0.6m | €0.5m | €0.5m | €0.7m | €0.6m | €1.0m | €1.0m | €1.2m | ▲ 22.2% |
| Fixed assets21/28 | €0.02m | €0.01m | €0.007m | €0.004m | €0.002m | €0.3m | €0.3m | €0.8m | ▲ 198% |
| Tangible fixed assets22/27 | €0.02m | €0.009m | €0.006m | €0.003m | €0.002m | €0.3m | €0.3m | €0.8m | ▲ 198% |
| Land and buildings22 | - | - | - | - | - | €0.3m | €0.3m | €0.6m | ▲ 110% |
| Plant, machinery and equipment23 | - | - | - | €0.003m | €0.002m | €0.004m | €0.002m | €0.05m | ▲ 22× |
| Furniture and vehicles24 | - | - | - | - | - | €0.007m | €0.004m | €0.2m | ▲ 54× |
| Financial fixed assets28 | €0.001m | €0.001m | €0.001m | €0.001m | - | - | - | - | - |
| Current assets29/58 | €0.5m | €0.5m | €0.5m | €0.7m | €0.6m | €0.7m | €0.7m | €0.3m | ▼ 49.7% |
| Stocks and contracts in progress3 | €0.05m | €0.05m | €0.05m | €0.04m | €0.04m | €0.07m | €0.09m | €0.1m | ▲ 16.3% |
| Stocks30/36 | - | - | - | €0.04m | €0.04m | €0.07m | €0.09m | €0.1m | ▲ 16.3% |
| Amounts receivable within one year40/41 | €0.05m | €0.04m | €0.03m | €0.04m | €0.05m | €0.4m | €0.2m | €0.2m | ▼ 30.5% |
| Trade receivables40 | - | - | - | €0.04m | €0.05m | €0.06m | €0.06m | €0.07m | ▲ 21.7% |
| Other amounts receivable41 | - | - | - | - | €33 | €0.3m | €0.2m | €0.1m | ▼ 46.6% |
| Current investments50/53 | €0.4m | €0.4m | €0.4m | €0.6m | €0.5m | €0.02m | €0.02m | €0.02m | = |
| Cash at bank and in hand54/58 | €0.03m | €0.02m | €0.06m | €0.02m | €0.06m | €0.3m | €0.3m | €0.06m | ▼ 82.7% |
| Deferred charges and accrued income490/1 | - | - | - | €0.01m | €0.002m | €0.002m | €28 | €0.002m | ▲ 71× |
| Equity and liabilities | |||||||||
| Total equity and liabilities10/49 | €0.6m | €0.5m | €0.5m | €0.7m | €0.6m | €1.0m | €1.0m | €1.2m | ▲ 22.2% |
| Equity10/15 | €0.4m | €0.4m | €0.4m | €0.5m | €0.5m | €0.5m | €0.5m | €0.5m | ▼ 4.3% |
| Contributions10/11 | €0.02m | €0.02m | - | €0.02m | €0.02m | €0.02m | €0.02m | €0.02m | = |
| Reserves13 | €0.5m | €0.5m | €0.5m | €0.5m | €0.5m | €0.5m | €0.5m | €0.5m | ▼ 4.4% |
| Non-distributable reserves130/1 | - | - | - | €0.002m | €0.002m | - | - | - | - |
| Reserves not available under the articles1311 | - | - | - | €0.002m | €0.002m | - | - | - | - |
| Tax-exempt reserves132 | - | - | - | €0.006m | €0.006m | €0.006m | €0.006m | €63 | ▼ 99.0% |
| Distributable reserves133 | - | - | - | €0.5m | €0.5m | €0.5m | €0.5m | €0.5m | ▼ 3.3% |
| Profit (loss) carried forward14 | -€0.04m | -€0.06m | -€0.06m | €0 | -€0.001m | - | - | - | - |
| Amounts payable17/49 | €0.1m | €0.1m | €0.1m | €0.2m | €0.1m | €0.5m | €0.5m | €0.7m | ▲ 52.5% |
| Amounts payable after more than one year17 | €0.001m | - | - | - | - | €0.2m | €0.2m | €0.4m | ▲ 83.6% |
| Financial debts170/4 | - | - | - | - | - | €0.2m | €0.2m | €0.4m | ▲ 83.6% |
| Amounts payable within one year42/48 | €0.1m | €0.1m | €0.1m | €0.2m | €0.1m | €0.3m | €0.2m | €0.3m | ▲ 22.1% |
| Current portion of amounts payable after more than one year42 | - | - | - | - | - | €0.008m | €0.009m | €0.03m | ▲ 219% |
| Trade debts44 | €0.02m | €0.02m | €0.02m | €0.02m | €0.02m | €0.2m | €0.1m | €0.07m | ▼ 29.9% |
| Suppliers440/4 | - | - | - | €0.02m | €0.02m | €0.2m | €0.1m | €0.07m | ▼ 29.9% |
| Taxes, remuneration and social security45 | - | - | - | €0.04m | €0.02m | €0.005m | €0.008m | €0.01m | ▲ 30.9% |
| Taxes450/3 | - | - | - | €0.02m | €0.009m | €0.005m | €0.008m | €0.01m | ▲ 30.9% |
| Remuneration and social security454/9 | - | - | - | €0.02m | €0.01m | - | - | - | - |
| Other amounts payable47/48 | - | - | - | €0.1m | €0.08m | €0.09m | €0.1m | €0.2m | ▲ 57.5% |
| Accrued charges and deferred income492/3 | - | - | - | €0.001m | €0.006m | €0.002m | €0.004m | €0.006m | ▲ 41.9% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€22,165 | -€17,755 | -€670 | €99,990 | -€1,090 | €10,031 | €22,738 | -€22,317 | - |
| + Depreciation and write-downs630 | €9,730 | €9,774 | €3,179 | €2,911 | €995 | €20,818 | €14,111 | €36,138 | ▲ 156% |
| Operating cash flow (approximation) | -€12,435 | -€7,980 | €2,508 | €102,901 | -€95 | €30,849 | €36,848 | €13,821 | ▼ 62.5% |
| Investment in fixed assets (approximation) | - | -€25 | €10 | €65 | €626 | -€317,623 | €0 | -€599,503 | - |
| Change in cash | - | -€405 | €31,741 | -€40,037 | €42,685 | €222,720 | €66,270 | -€287,975 | - |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Historical observation
In July 2024, 12,322 companies had the same profile as DALEMANS has now. Two years later, 90.3% were still going and 0.7% had gone bankrupt.
- Micro
- 20 years or older
- solvency 30% or more
- a small loss
90.3%
was still going
8.6%
stopped otherwise
0.7%
went bankrupt
Another 0.5% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of DALEMANS itself is higher: 0.9% within 12 months. It rests on far more data about DALEMANS than the profile alone.
Test of the method
The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 12,322 companies, not a prediction for DALEMANS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Latest 10 of 46 filings with the National Bank
| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | abbreviated format | 31-08-2026 | 2026-00479212 | |
| 31-12-2024 | abbreviated format | 13-10-2025 | 2025-00540805 | |
| 31-12-2023 | abbreviated format | 26-09-2024 | 2024-00474328 | |
| 31-12-2022 | micro format | 22-12-2023 | 2023-00536468 | |
| 31-12-2021 | micro format | 26-08-2022 | 2022-20382469 | |
| 31-12-2020 | micro format | 30-08-2021 | 2021-63900437 | |
| 31-12-2019 | abbreviated format | 28-08-2020 | 2020-48500051 | |
| 31-12-2018 | abbreviated format | 27-08-2019 | 2019-56600324 | |
| 31-12-2017 | abbreviated format | 27-08-2018 | 2018-52000332 | |
| 31-12-2016 | abbreviated format | 30-08-2017 | 2017-54100480 |
Board & ownership
Directors
Directors
1 director, no change since 2023
Board 1
DALI
Current
Director (not named in the articles) · appointed in the act of 07-02-2023 · term without a fixed end · Private limited company · permanent representative: DALEMANS Carla · listed in the 2025 annual accounts, filed on 31-08-2026
Permanent representatives 1
DALEMANS Carla
Current
Permanent representative · appointed in the act of 07-02-2023 · for DALI
Signing authorityThe articles say who may bind the company, for example by signing a contract.
Each director alone
deed of 07-02-2023Owners and capital
Shareholders
1 ownerChain of control
- DALI
- DALEMANS
Owners 1
- DALIparentSourceaccounts DALI 2025Equity €114,209 Profit of €56,955 in 2025 (profit of €42,512 in 2024)100%
Capital transactions
Capital over time
- 07-02-2023 Converted to available equity
Mandate history
2 people, 1 in office
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| DALI |
|
| DONCEEL Reinildis |
|
Network & group
Connections & network
1 current directorThe network starts from the directors of DALEMANS. Every other company they run is a node.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Timeline
Acts, filings and financial milestones
Deadline for the 2026 accounts:
2026
31-08
abbreviated format · 31 days late
16-07
Gazette deed
Registered office moved within BuggenhoutNew seat: Paul Van Malderenplein 5, 9255 Buggenhout · Previous seat: Kerkstraat 75, 9255 Buggenhout2 points ▸
Gazette deed
Registered office moved within Buggenhout
New seat: Paul Van Malderenplein 5, 9255 Buggenhout · Previous seat: Kerkstraat 75, 9255 Buggenhout2 points ▸
- General meeting, 15-04-2026
- Registered-office move, Paul Van Malderenplein 5, 9255 Buggenhout
2025
31-12
Financial
Weakest financial yearnet -€22,317
The net result drops to -€22,317, the lowest from 2018 to 2025.
13-10
abbreviated format · 74 days late
2024
26-09
abbreviated format · 57 days late
2023
31-12
Financial
Back to profitnet €10,031
The net result is €10,031, after one loss-making year.
22-12
micro format · 144 days late
07-02
Gazette deed
Company renamed from MARC ADRIAENSSENS to DalemansResignation: DONCEEL Reinildis (statutory manager) · Appointment: DALI (director) · Permanent representative: DALEMANS Carla14 points ▸
Gazette deed
Company renamed from MARC ADRIAENSSENS to Dalemans
Resignation: DONCEEL Reinildis (statutory manager) · Appointment: DALI (director) · Permanent representative: DALEMANS Carla14 points ▸
- General meeting, 31-01-2023
- Other provision, 01-01-2020, “onderworpenheid aan dwingende bepalingen WVV” (deed in Dutch)
- Capital conversion, “beschikbaar voor uitkering” (deed in Dutch)
- Director resignation, DONCEEL Reinildis (statutory manager)
- Director discharge, DONCEEL Reinildis
- Name change, Dalemans
- Other provision, “verslag bestuursorgaan tot aanpassing voorwerp, bestuursorgaan” (deed in Dutch)
- Purpose change
- Other provision, “uittreksel, aanneming van volledig nieuwe statuten” (deed in Dutch)
- Other provision, “coördinatie opmaken en ondertekenen en neerlegging in vennootschapsdossier verzorgen, opdracht coördinatie statuten” (deed in Dutch)
- Director appointment, DALI (director (not named in the articles))
- Permanent representative, DALEMANS Carla
- The act holds 2 more points.
2022
26-08
micro format · 26 days late
2021
31-12
Financial
Back to profitnet €99,990
The net result is €99,990, after 3 loss-making years.
31-12
Financial
Equity above €500,000equity €513,724 ▲24.2%
Equity rises from €413,733 to €513,724.
30-08
micro format · 30 days late
Show earlier events
2020
28-08
abbreviated format · 28 days late
2019
27-08
abbreviated format · 27 days late
2018
27-08
abbreviated format · 27 days late
2017
30-08
abbreviated format · 30 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank
History
DALEMANS was incorporated on 21 December 1979.1 The name was changed to Dalemans in 2023.2 The registered office was moved to Buggenhout in 2026.3 DALI is director of the company, appointed in the act of 07-02-2023.2 Total assets rose from €551,985 in 2018 to €1.2m in 2025 and headcount from 1 to 1 full-time equivalents.4
Company details
Register details
Identity
KBO recordName
DALEMANS in Dutch
Former name
MARC ADRIAENSSENS until the act of 07-02-2023
Enterprise number
0419.971.002
Legal form
Private limited company
Status
Active, normale toestand
Founded
21-12-1979
Entity type
Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 07-02-2023 (in Dutch)Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
“Voor zover geen wijziging van toepasselijk taalregime, Vlaams Gewest”
deed of 07-02-2023 (in Dutch)Registered office and establishments
Registered office
Paul Van Malderenplein 5, 9255 Buggenhout, Belgium
Establishment unit
Paul Van Malderenplein 5, 9255 Buggenhout since 01-01-1980 · unit number 2.016.972.567
Activities
NACEBEL 2025VAT activities
47730
Retail sale of pharmaceutical products main activity
Social security (RSZ) activities
47730
Retail sale of pharmaceutical products main activity
Codes under NACEBEL 2008
47730
Retail trade main activity
Codes under NACEBEL 2003
52310
main activity
Joint committee
313 Paritair Comité voor de apotheken en tarificatiediensten annual accounts 2021
PurposeThe purpose describes the activities the company may carry out under its articles.
deed of 07-02-2023 (in Dutch)
“Het verlenen van strategisch,bedrijfseconomisch,technisch,financieel en juridisch advies,management,administratie en marketing voor…”
22 activities
- Het verlenen van strategisch,bedrijfseconomisch,technisch,financieel en juridisch advies,management,administratie en marketing voor ondernemingen,instellingen en verenigingen
- Het oprichten,overnemen,verkopen,inhuurnemen en uitbaten van apotheken en aanverwante (para)medische activiteiten
- Het beheer,de uitbating van één of meerdere apotheken voor eigen rekening of voor rekening van derden,overeenkomstig de deontologische gedragsregels eigen aan de uitoefening van het beroep,de groot- en kleinhandel,de aan- en verkoop,de in- en uitvoer alsook de bereiding van alle soorten chemische,farmaceutische,parafarmaceutische,fytofarmaceutische,homeopathische preparaten,magistrale bereidingen,huisbereidingen of officinale bereidingen eigen aan de apotheek,hygiënische producten,pesticiden en specialiteiten,inbegrepen cosmetica,parfumerie,baby-,dieet-,kinder-,sport-,TPN (Total Parenteral Nutrition) en natuurvoeding;voedingssupplementen in de ruimste zin van het woord alsook de groot- en kleinhandel,de aan- en verkoop,de productie en herstel van alle soorten medische hulpmiddelen en –materialen daarin vervat gezichts- en gehoorapparaten,bloeddrukmeters en toebehoren,glucosemeettoestellen met toebehoren,hulpmiddelen om te stoppen met roken (de elektronische sigaret en toebehoren),spirometers van alle soorten artikelen,producten,toestellen en voorwerpen in verband met bandagisterie en orthopedie alsook in verband met het uitvoeren van klinische analyses,veterinaire producten en instrumenten met inbegrip van artikelen voor kleine huisdieren en neerhofdieren,alles in de meest ruime zin van het woord en zonder enige beperking,medische- en onderhoudsproducten en van alle artikels in verband met optiek en macro-biotiek alsook alle apparatuur,materialen en diensten die met voorgaande verband houden.
- Het opnemen van industriële,klinische,medische,biologische,scheikundige en toxicologische analyses
- Het waarnemen van bestuursmandaten,begeleiding,management en consultancy in de geneesmiddelen- en apotheeksector
- Het onderzoek,de ontwikkeling,de vervaardiging of commercialisering van nieuwe producten,nieuwe vormen van technologie en hun directe of indirecte toepassingen.
- Iedere handelsbedrijvigheid die met de gezondheidszorg in de ruimste zin verband houdt.
- De uitbating van een centrum voor wellness,fitness,lichaamsverzorging,relaxatietherapie en aanverwante activiteiten,alsook iedere handelsbedrijvigheid die met de gezondheidszorg in de ruimste zin verband houdt
- Het optreden als vervanger in apotheken.
- De studie,de uitbating,de vertegenwoordiging van brevetten,patenten,licenties,merken,know how,rechten van het intellectuele patrimonium. De handel onder al zijn vormen,van producten die hun oorsprong vinden in de commercialisatie van bovenvermelde rechten. Zij mag eveneens alle fabrieksmerken,octrooien en andere eruit voortvloeiende of aanvullende rechten verwerven en tegelde maken en deelnemen aan de opbouw,de ontwikkeling en het beheer van alle vennootschappen.
- Het uitvoeren van alle studies en onderzoek;het verrichten van marktonderzoek;promotie,raadgeving;prospectie;marketing;assistentie op gebied van management,engineering en consulting;technisch,commercieel,administratief,financieel,fiscaal en juridisch beheer en advies.
- Het verlenen van advies in verband met informaticaprogramma’s en de realisatie van programma’s,ontwerpen en supporteren van digitale ontwikkelingen,het maken van websites en daarmee verband houdende activiteiten
- De publiciteit,reclame,marketing en algemene communicatie onder alle vormen en het uitvoeren van alle werken die voor de verwezenlijking van publiciteit,reclame,marketing en algemene communicatie noodzakelijk zijn,zonder enige beperking.
- Het ontwerpen,uitgeven en verspreiden van allerlei drukwerken zoals (maar niet beperkt tot) flyers,logo’s,wetenschappelijke publicaties…
- Allerhande opleidingen en cursussen geven,seminaries,voordrachten,presentaties en workshops in de meest ruime zin van het woord,organiseren voor intern gebruik maar ook naar externen/derden toe.
- Het aanbieden,organiseren,begeleiden en uitvoeren van evenementen en feestelijkheden zowel voor volwassenen als voor kinderen,eveneens met ter beschikking stelling van de ruimten daartoe.
- Het aanbieden,organiseren en begeleiden en uitvoeren van workshops,in eigen naam of als tussenpersoon,op het gebied van koken of andere manipulaties van voedingswaren en voedingstoebehoren.
- De klein- en groothandel in diverse voedingswaren,al dan niet zelf ontwikkeld,en hun toebehoren.
- Klaarmaken,thuisbezorgen en mogelijks serveren van bereide gerechten.
- De aankoop en verkoop,zowel in groot- als kleinhandel,trading,de import,de export,de agentuur,de vertegenwoordiging,de commissiehandel,de ruiling en de verhuring,inclusief de diverse vormen van leasing,van allerlei producten (zowel commerciële,grondstoffen,half grondstoffen,fabricaten en afgewerkte producten van alle aard en dit in de meest ruime zin) voor zover door de wet toegelaten.
- Het waarnemen van alle mandaten,waaronder bestuurder,zaakvoerder of vereffenaar in andere vennootschappen en verenigingen
- Het huren,verhuren,aankopen,verkopen en beheren van onroerende goederen
Invoicing and payment
VAT number
BE 0419.971.002
Financial year and general meeting
Accounts at the NBBFinancial year end
31-12
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Last Friday of June
deed of 07-02-2023 (in Dutch)Environmental permits
1 application in Flanders since 2025 · 1 granted
Nieuwe publiciteitsinrichting (met inbegrip van vernieuwen van een bestaande vergunning); Verbouwen en/of uitbreiden met functiewijziging, maar zonder wijziging van het aantal woongelegenheden
Source: Omgevingsloket Vlaanderen.
Sites & property
Location
Buildings and parcels at the address
Ground area
285 m²
Building footprint
201 m²
Building volume
842 m³
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 42004A0044/00N003 | Flanders | 285 m² | 1 · 201 m² | 5.3 m · 1 |